Abstract
Despite the availability of technologies and guidelines recommendations, invasive coronary function testing (IFT) remains underperformed in patients with ischemia with no obstructive coronary artery disease (INOCA), but the current state of IFT in Canadian cardiac catheterization laboratories (CCL) remained unknown. Therefore, we conducted an survey among Canadian CCL directors(n=46). While most CCL directors believed that IFT should be performed in INOCA patients experience persisting symptoms or adverse clinical outcomes, only 19.6% (n=9) and 30.4% (n=14) of responding centers performed invasive assessment of the microvasculature and vasomotor function, respectively.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
